跳至主要内容
临床试验/IRCT20191221045837N2
IRCT20191221045837N2招募中2 期

Evaluation of the Efficacy of Nanomicelle Curcumin Formulation in Children with Ulcerative Colitis (UC)

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 18 years(—)
性别
All

入选标准

  • Children 6-18 years old who , according to the ESPHAN Guideline , have mild to moderate active Ulcerative Colitis
  • Obtain informed consent from the patient/ patient's parents

排除标准

  • Child with a history of underlying disease including heart, kidney, liver, biliary, gastrointestinal diseases (any gastrointestinal disease other than UC) simultaneously
  • Taking anticoagulants such as warfarin or antiplatelet drugs by the patient
  • Diabetic patients

研究者

相似试验